NASONEX 24HR ALLERGY Drug Patent Profile
✉ Email this page to a colleague
When do Nasonex 24hr Allergy patents expire, and what generic alternatives are available?
Nasonex 24hr Allergy is a drug marketed by Perrigo Pharma Intl and is included in one NDA.
The generic ingredient in NASONEX 24HR ALLERGY is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nasonex 24hr Allergy
A generic version of NASONEX 24HR ALLERGY was approved as mometasone furoate by PADAGIS US on March 18th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NASONEX 24HR ALLERGY?
- What are the global sales for NASONEX 24HR ALLERGY?
- What is Average Wholesale Price for NASONEX 24HR ALLERGY?
Summary for NASONEX 24HR ALLERGY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Clinical Trials: | 60 |
| Patent Applications: | 5,365 |
| DailyMed Link: | NASONEX 24HR ALLERGY at DailyMed |
Recent Clinical Trials for NASONEX 24HR ALLERGY
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yingu Pharmaceutical Co., Ltd | Phase 4 |
| Centre hospitalier de l'Université de Montréal (CHUM) | Phase 4 |
| EMS | Phase 3 |
Pharmacology for NASONEX 24HR ALLERGY
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for NASONEX 24HR ALLERGY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Perrigo Pharma Intl | NASONEX 24HR ALLERGY | mometasone furoate | SPRAY, METERED;NASAL | 215712-001 | Mar 17, 2022 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
